Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present GW Pharmaceuticals Plc. (OTC: GWPRF).

Full DD Report for GWPRF

You must become a subscriber to view this report.


Recent News from (OTC: GWPRF)

CannaRoyalty divests its 6.14% equity stake in AltMed to Tidal Royalty
CannaRoyalty ( OTCQX:CNNRF +11.1% )  enters into a binding letter of intent with Tidal Royalty ( OTCPK:TDRYF -2.3% ) whereby Tidal Royalty will acquire CNNRF's equity stake and royalty entitlement in Alternative Medical Enterprises or AltMed More news on: CannaRoyalty Corp., Tida...
Source: SeekingAlpha
Date: August, 27 2018 10:39
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (Cannabidiol) Study in The Lancet
LONDON and CARLSBAD, California , January 24, 2018 /PRNewswire/ -- -   First well-controlled clinical study of cannabidiol in Lennox-Gastaut syndrome, a rare, severe, form of childhood-onset epilepsy that is difficult to treat   -     -   Pharmaceutic...
Source: PR Newswire
Date: January, 24 2018 18:30
Horizons Marijuana Life Sciences Index ETF Is A Best Bet For The Passive Marijuana Investor
Note: This article contains both Canadian- and U.S.-traded ticker symbols. Caution should be exercised with these gray-market derivatives. The Horizons Marijuana Life Sciences Index ETF (HMLSF) has performed well, and there is no reason to expect otherwise as 2018 progresses. I ...
Source: SeekingAlpha
Date: January, 03 2018 11:10
An Overview Of The Cannabis Industry
29 states and the District of Columbia have now legalized cannabis for medical and/or recreational purposes and public acceptance of cannabis continues to increase at a rapid pace. Cannabis has also shown encouraging signs as a treatment for various medical conditions and ailments, which shoul...
Source: SeekingAlpha
Date: December, 27 2017 08:57
Jonathan Faison Positions For 2018: Faster FDA Approval, Emerging Sector In China Bode Well For Biotech Next Year
An 11-year Seeking Alpha member, author Jonathan Faison focuses on discovering under-the-radar stocks and alpha-generating ideas for his readers. Operating primarily in the biotech sector, his specialty is looking specifically for opportunities to achieve high percentage gains within a year's ...
Source: SeekingAlpha
Date: December, 20 2017 10:00
Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com
SAN ANTONIO , Dec. 11, 2017 /PRNewswire/ --  Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international, vertically-integrated medical cannabis company, today announced that the Dec. 7th investor presentation and webcast from Alternate He...
Source: PR Newswire
Date: December, 11 2017 08:35

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1710.8010.3110.809.603,653
2018-12-1410.0510.0510.0510.05333
2018-12-1310.1510.026511.0010.005,050
2018-12-1210.1510.7510.7510.152,489
2018-12-1110.009.9510.049.891,171

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-171,0043,65327.4843Cover
2018-12-1421533364.5646Short
2018-12-133,0585,05060.5545Short
2018-12-12202,4890.8035Cover
2018-12-113901,17133.3049Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GWPRF.


About GW Pharmaceuticals Plc. (OTC: GWPRF)

Logo for GW Pharmaceuticals Plc. (OTC: GWPRF)

GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group s lead programme is the development of a product portfolio of cannabinoid prescription medicines , including Sativex Oromucosal Spray, to meet patient needs in a wide range of therapeutic indications lt br / gt GW has assembled a large in house team with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant based prescription pharmaceutical products. GW also holds GMP manufacturing licences for the manufacture of pharmaceutical products for both clinical trials and commercial purposes.

 

Contact Information

 

 

Current Management

  • David Kirk / Finance Director
  • Geoffrey Guy / Executive Chairman

Current Share Structure

  • Market Cap: $1,348,383,400 - 03/15/2018
  • Issue and Outstanding: 131,549,600 - 03/31/2011

 


Recent Filings from (OTC: GWPRF)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 19 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 19 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 06 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 03 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 14 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 14 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 13 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 06 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: February, 23 2018

 

 


Daily Technical Chart for (OTC: GWPRF)

Daily Technical Chart for (OTC: GWPRF)


Stay tuned for daily updates and more on (OTC: GWPRF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: GWPRF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GWPRF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GWPRF and does not buy, sell, or trade any shares of GWPRF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/